BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Art Pappas will speak on "Later Stage Venture Funding" at the University of North Carolina at Chapel Hill's Technology Commercialization Workshop in Chapel Hill.
News | 10. 21. 2010
